dbACP: A Comprehensive Database of Anti-Cancer Peptides

24 result(s) have been found!

Accession Name Sequence Source/Organism Mechanism Assay Type Cell Line Cancer Type Activity
dbacp08112 FR-15 FRRFFKWFRRFFKFF Synthetic Proline-substituted AMP triggers mitochondrial apoptosis MTT assay MDA-MB-231 Breast Cancer IC50 = 3.15 μM
dbacp08113 FR-15 FRRFFKWFRRFFKFF Synthetic Proline-substituted AMP triggers mitochondrial apoptosis MTT assay HeLa Cervical Cancer IC50 = 4.9 μM
dbacp08114 FR-15 FRRFFKWFRRFFKFF Synthetic Proline-substituted AMP triggers mitochondrial apoptosis MTT assay DLD-1 Colon Cancer IC50 = 6.7 μM
dbacp08115 FR-15 FRRFFKWFRRFFKFF Synthetic Proline-substituted AMP triggers mitochondrial apoptosis MTT assay HepG-2 Liver Cancer IC50 = 2.5 μM
dbacp08116 FR4P FRRPFKWFRRFFKFF Analogue of FR-15 Proline-substituted AMP triggers mitochondrial apoptosis MTT assay MDA-MB-231 Breast Cancer IC50 = 6.3 μM
dbacp08117 FR4P FRRPFKWFRRFFKFF Analogue of FR-15 Proline-substituted AMP triggers mitochondrial apoptosis MTT assay HeLa Cervical Cancer IC50 = 7.7 μM
dbacp08118 FR4P FRRPFKWFRRFFKFF Analogue of FR-15 Proline-substituted AMP triggers mitochondrial apoptosis MTT assay DLD-1 Colon Cancer IC50 = 9.4 μM
dbacp08119 FR4P FRRPFKWFRRFFKFF Analogue of FR-15 Proline-substituted AMP triggers mitochondrial apoptosis MTT assay HepG-2 Liver Cancer IC50 = 2.5 μM
dbacp08120 FR8P FRRFFKWPRRFFKFF Analogue of FR-15 Proline-substituted AMP triggers mitochondrial apoptosis MTT assay MDA-MB-231 Breast Cancer IC50 = 6.4 μM
dbacp08121 FR8P FRRFFKWPRRFFKFF Analogue of FR-15 Proline-substituted AMP triggers mitochondrial apoptosis MTT assay HeLa Cervical Cancer IC50 = 10.5 μM
dbacp08122 FR8P FRRFFKWPRRFFKFF Analogue of FR-15 Proline-substituted AMP triggers mitochondrial apoptosis MTT assay DLD-1 Colon Cancer IC50 = 10.8 μM
dbacp08123 FR8P FRRFFKWPRRFFKFF Analogue of FR-15 Proline-substituted AMP triggers mitochondrial apoptosis MTT assay HepG-2 Liver Cancer IC50 = 4.2 μM
dbacp08124 FR11P FRRFFKWFRRPFKFF Analogue of FR-15 Proline-substituted AMP triggers mitochondrial apoptosis MTT assay MDA-MB-231 Breast Cancer IC50 = 7 μM
dbacp08125 FR11P FRRFFKWFRRPFKFF Analogue of FR-15 Proline-substituted AMP triggers mitochondrial apoptosis MTT assay HeLa Cervical Cancer IC50 = 11 μM
dbacp08126 FR11P FRRFFKWFRRPFKFF Analogue of FR-15 Proline-substituted AMP triggers mitochondrial apoptosis MTT assay DLD-1 Colon Cancer IC50 = 12.9 μM
dbacp08127 FR11P FRRFFKWFRRPFKFF Analogue of FR-15 Proline-substituted AMP triggers mitochondrial apoptosis MTT assay HepG-2 Liver Cancer IC50 = 4.8 μM
dbacp08128 FR4,8P FRRPFKWPRRFFKFF Analogue of FR-15 Proline-substituted AMP triggers mitochondrial apoptosis MTT assay MDA-MB-231 Breast Cancer IC50 = 15.4 μM
dbacp08129 FR4,8P FRRPFKWPRRFFKFF Analogue of FR-15 Proline-substituted AMP triggers mitochondrial apoptosis MTT assay HeLa Cervical Cancer IC50 = 13.8 μM
dbacp08130 FR4,8P FRRPFKWPRRFFKFF Analogue of FR-15 Proline-substituted AMP triggers mitochondrial apoptosis MTT assay DLD-1 Colon Cancer IC50 = 15.3 μM
dbacp08131 FR4,8P FRRPFKWPRRFFKFF Analogue of FR-15 Proline-substituted AMP triggers mitochondrial apoptosis MTT assay HepG-2 Liver Cancer IC50 = 5 μM
dbacp08132 FR8,11P FRRFFKWPRRPFKFF Analogue of FR-15 Proline-substituted AMP triggers mitochondrial apoptosis MTT assay MDA-MB-231 Breast Cancer IC50 = 27 μM
dbacp08133 FR8,11P FRRFFKWPRRPFKFF Analogue of FR-15 Proline-substituted AMP triggers mitochondrial apoptosis MTT assay HeLa Cervical Cancer IC50 = 18.9 μM
dbacp08134 FR8,11P FRRFFKWPRRPFKFF Analogue of FR-15 Proline-substituted AMP triggers mitochondrial apoptosis MTT assay DLD-1 Colon Cancer IC50 = 22 μM
dbacp08135 FR8,11P FRRFFKWPRRPFKFF Analogue of FR-15 Proline-substituted AMP triggers mitochondrial apoptosis MTT assay HepG-2 Liver Cancer IC50 = 15 μM